1. Home
  2. MRBK vs ANIK Comparison

MRBK vs ANIK Comparison

Compare MRBK & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$19.94

Market Cap

228.9M

Sector

Finance

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.74

Market Cap

198.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
ANIK
Founded
2004
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.9M
198.9M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
MRBK
ANIK
Price
$19.94
$14.74
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$20.75
$17.00
AVG Volume (30 Days)
94.9K
56.8K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
3.05%
N/A
EPS Growth
30.34
80.16
EPS
0.17
N/A
Revenue
$6,316,000.00
$112,819,000.00
Revenue This Year
$25.40
$5.98
Revenue Next Year
$8.15
$7.42
P/E Ratio
$115.00
N/A
Revenue Growth
10.13
N/A
52 Week Low
$11.87
$7.90
52 Week High
$21.59
$16.24

Technical Indicators

Market Signals
Indicator
MRBK
ANIK
Relative Strength Index (RSI) 65.72 51.78
Support Level $18.32 $13.91
Resistance Level $20.74 $15.08
Average True Range (ATR) 0.58 0.51
MACD 0.07 -0.00
Stochastic Oscillator 76.02 68.98

Price Performance

Historical Comparison
MRBK
ANIK

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: